Get Started

LNAI

NASD Lunai Bioworks, Inc.
Oct 27, 2026 · 1:06 AM ET EOD Market Closed

$0.2750 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2750, $0.0266 below the day’s high of $0.3016

YTD change
-96.10%
vs 20-day SMA
-72.90%
vs 200-day SMA
-91.00%

Price ranges

Previous day
$0.2265 $0.3156
open $0.2600 close $0.2946
+$0.0346 (+13.31%)
Today
$0.2327 $0.3016
open $0.2629 now $0.2750
+$0.0121 (+4.60%)
Past week
$0.2265 $0.6952
from $0.6804 now $0.2750
-$0.4054 (-59.58%)
Past month
$0.2265 $2.0500
from $1.9300 now $0.2750
-$1.6550 (-85.75%)
This year
$0.1513 $7.0536
from $7.0536 now $0.2750
-$6.7786 (-96.10%)

Price & Performance

-0.03 (-10.89%) / 6M

$-0.1013$1.47$3.05$4.63Apr 27Jul 28Oct 26

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.9% away from all-time highs of $13.2800
  • LNAI is down 96% since the beginning of the year
  • LNAI is down 97% over the past 12 months
  • LNAI is down 86% over the past 1 month
  • 3% of all LNAI investors are betting against LNAI

LNAI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -73.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.4356
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $614.8K
Beta 1.55

Balance sheet & scale

IncomeN/A
Revenue$52.0K
Cash$1.7M
Debt$1.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.4M

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Sacramento, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $444.63 +1.22%
MRNA Moderna, Inc. $198.85 -0.62%
RVMD Revolution Medicines, Inc. $183.90 -1.65%
ROIV Roivant Sciences Ltd. $36.05 -1.21%
BNTX BioNTech SE Sponsored ADR $86.86 -1.42%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.